{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/prov/279376631"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/407752117" ] } },

    { "id" : "http://webisa.webdatacommons.org/407752117"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "It has ongoing Phase 2 and Phase 1/2 clinical trials to evaluate the safety and efficacy of a novel ZFP Therapeutic?? for the treatment of HIV/AIDS.Sangamo's other therapeutic programs are focused on monogenic diseases, including hemophilia and hemoglobinopathies such as sickle cell anemia and beta-thalassemia, and a program in Parkinson's disease." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "bio-medicine.org" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/406907676"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/407752117" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/443160642"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/407752117"] } } }
